Cost of Revenue in USD of NRX Pharmaceuticals, Inc. from Q3 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NRX Pharmaceuticals, Inc. quarterly Cost of Revenue history and growth rate from Q3 2024 to Q3 2025.
  • NRX Pharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2025 was $97K.
Cost of Revenue, Quarterly (USD)

NRX Pharmaceuticals, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $97K +$97K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.